A dispute over the documentation to the medicine Esbriet shows how much controversy is stirred up by the disclosure of registration documents for medicines to third parties. How to balance the interests of innovative pharmaceutical companies, manufacturers of cheaper generics, and doctors who seek full knowledge of the safety and efficacy of the drugs they prescribe?
The dynamic growth in market share of functional foods calls for a critical review of myths that have arisen around R&D projects in the food sector.
The Polish parliament is currently discussing draft amendments to the Law on Food Safety and Nutrition which aims to eliminate unhealthy food from school shops and to prohibit all forms of promotion of unhealthy foods within educational institutions.
In times of fierce market competition, it is becoming increasingly attractive to construct advertising campaigns that contain superlatives, in particular regarding market leadership.
An interview with Prof. Jan Lubiński, geneticist and researcher into the role of microelements in prevention of cancer, founder and CEO of Read-Gene SA, and member of the Council of the National Centre for Research and Development.
On 11 February 2014 the Warsaw Regional Court issued a long-awaited ruling demonstrating the current approach of the Polish courts to the sensitive issue of how to designate promotional prices for goods.